With the ongoing uncertainties surrounding COVID-19, a pertinent question arises: Should individuals who rely on CPAP machines for sleep apnea continue their therapy if diagnosed with the virus? The implications seem significant and multifaceted. On one hand, CPAP users may experience worsening symptoms without their equipment, leading to a decline in overall health and well-being. However, the concern heightens regarding the potential for aerosol generation and transmission, which could pose risks to both the user and those around them. What if the machine inadvertently contributes to the spread of the virus within their environment? Furthermore, how do underlying factors, such as the severity of COVID-19 symptoms or the presence of additional comorbidities, influence this decision? In light of these considerations, one might ponder the balance between adhering to necessary sleep therapy and mitigating the risk of further contagion. These complexities invite a thorough exploration into the intersection of respiratory health and infectious disease.